Amanote Research
Register
Sign In
Preliminary Safety Assessment of Eudragit® Polymers Nanoparticles Administration in the Rat Brain
Journal of Applied Pharmaceutical Science
- India
doi 10.7324/japs.2017.70726
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Toxicology
Pharmaceutics
Pharmacology
Date
January 1, 2017
Authors
Unknown
Publisher
Journal of Applied Pharmaceutical Science
Related search
Desloratadine-Eudragit® RS100 Nanoparticles: Formulation and Characterization
Turkish Journal of Pharmaceutical Sciences
Molecular Medicine
Pharmaceutical Science
Eudragit Nanoparticles Containing Genistein: Formulation, Development, and Bioavailability Assessment
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Topaz II Preliminary Safety Assessment
AIP Conference Proceedings
Astronomy
Physics
An Evaluation of the in Vivo Safety of Nonporous Silica Nanoparticles: Ocular Topical Administration Versus Oral Administration
Scientific Reports
Multidisciplinary
The Development of Eudragit® NM-Based Controlled-Release Matrix Tablets
Medicina
Medicine
Oral Administration of Tocotrienol Ameliorates Lead-Induced Toxicity in the Rat Brain
Medicine & Health
Neutrotoxic Effects of Fructose Administration in Rat Brain: Implications for Fructosemia
Anais da Academia Brasileira de Ciencias
Multidisciplinary
Formulation and in Vitro Evaluation of Theophylline-Eudragit® Sustained-Release Tablets
Revista Brasileira de Ciências Farmacêuticas
Metabolic, Gastrointestinal, and CNS Neuropeptide Effects of Brain Leptin Administration in the Rat
American Journal of Physiology - Regulatory Integrative and Comparative Physiology
Physiology
